Grace M - Search Results

1

Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer.

Wen SF, Mahavni V, Quijano E, Shinoda J, Grace M, Musco-Hobkinson ML, Yang TY, Chen Y, Runnenbaum I, Horowitz J, Maneval D, Hutchins B, Buller R. Wen SF, et al. Among authors: grace m. Cancer Gene Ther. 2003 Mar;10(3):224-38. doi: 10.1038/sj.cgt.7700562. Cancer Gene Ther. 2003. PMID: 12637944 Clinical Trial.

2

Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.

Atencio IA, Grace M, Bordens R, Fritz M, Horowitz JA, Hutchins B, Indelicato S, Jacobs S, Kolz K, Maneval D, Musco ML, Shinoda J, Venook A, Wen S, Warren R. Atencio IA, et al. Among authors: grace m. Cancer Gene Ther. 2006 Feb;13(2):169-81. doi: 10.1038/sj.cgt.7700870. Cancer Gene Ther. 2006. PMID: 16082381 Clinical Trial.

3

Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation.

Kuball J, Wen SF, Leissner J, Atkins D, Meinhardt P, Quijano E, Engler H, Hutchins B, Maneval DC, Grace MJ, Fritz MA, Störkel S, Thüroff JW, Huber C, Schuler M. Kuball J, et al. Among authors: grace mj. J Clin Oncol. 2002 Feb 15;20(4):957-65. doi: 10.1200/JCO.2002.20.4.957. J Clin Oncol. 2002. PMID: 11844817 Clinical Trial.

4

The use of field emission scanning electron microscopy to assess recombinant adenovirus stability.

Obenauer-Kutner LJ, Ihnat PM, Yang TY, Dovey-Hartman BJ, Balu A, Cullen C, Bordens RW, Grace MJ. Obenauer-Kutner LJ, et al. Among authors: grace mj. Hum Gene Ther. 2002 Sep 20;13(14):1687-96. doi: 10.1089/104303402760293538. Hum Gene Ther. 2002. PMID: 12396622

5

The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.

Grace MJ, Xie L, Musco ML, Cui S, Gurnani M, DiGiacomo R, Chang A, Indelicato S, Syed J, Johnson R, Nielsen LL. Grace MJ, et al. Am J Pathol. 1999 Dec;155(6):1869-78. doi: 10.1016/S0002-9440(10)65506-X. Am J Pathol. 1999. PMID: 10595917 Free PMC article.

6

Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector.

Zhu J, Grace M, Casale J, Chang AT, Musco ML, Bordens R, Greenberg R, Schaefer E, Indelicato SR. Zhu J, et al. Among authors: grace m. Hum Gene Ther. 1999 Jan 1;10(1):113-21. doi: 10.1089/10430349950019246. Hum Gene Ther. 1999. PMID: 10022536

7

Interferon-alpha as an immunotherapeutic protein.

Brassard DL, Grace MJ, Bordens RW. Brassard DL, et al. J Leukoc Biol. 2002 Apr;71(4):565-81. J Leukoc Biol. 2002. PMID: 11927642 Review.

8

Pegylated IFNs for chronic hepatitis C: an update.

Grace MJ, Cutler DL, Bordens RW. Grace MJ, et al. Expert Opin Drug Deliv. 2005 Mar;2(2):219-26. doi: 10.1517/17425247.2.2.219. Expert Opin Drug Deliv. 2005. PMID: 16296749 Review.

9

Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications.

Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF. Wang YS, et al. Among authors: grace m. Adv Drug Deliv Rev. 2002 Jun 17;54(4):547-70. doi: 10.1016/s0169-409x(02)00027-3. Adv Drug Deliv Rev. 2002. PMID: 12052714 Review.

10

Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.

Youngster S, Wang YS, Grace M, Bausch J, Bordens R, Wyss DF. Youngster S, et al. Among authors: grace m. Curr Pharm Des. 2002;8(24):2139-57. doi: 10.2174/1381612023393242. Curr Pharm Des. 2002. PMID: 12369859 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

990 results

Search Page